RSS

insulin

A device that takes inspiration from a spider’s web that may be a game-changer in the control of Type 1 diabetes has been developed by researchers from Cornell University. more

Technology

Here we count down the top five tweets from @EPM_magazine that have gained the most impressions this week, taken from Twitter analytics. more

News

Phillips-Medisize has entered into an agreement with biotechnology company Dance Biopharm to develop a connected insulin inhaler. more

Technology

Global healthcare company, Novo Nordisk, has revealed that the US Food and Drug Administration (FDA) has approved its fast-acting mealtime insulin, Fiasp, for the improvement of glycaemic control in adults with diabetes. more

Technology

A potential new therapy for type I diabetes patients has been found to be safe and does not accelerate decline in β cell function — important in the production of insulin — in a recently published clinical trial. more

News

Amrita Banerjee, post-doctoral scholar, University of California Santa Barbara talks oral insulin and needle-free delivery of protein more

Opinion

Novo Nordisk has submitted a New Drug Application (NDA) for a faster-acting insulin aspart to the US Food and Drug Administration (FDA) more

News

EPM selects five noteworthy drugs and drug delivery developments from the past month more

News

Researchers have developed an intestinal patch device containing insulin that can be swallowed in a capsule more

News

Cambridge Consultants has won a Red Dot Design Award for its KiCoPen smart insulin pen concept more

News

Y. Shashidhar, partner & managing director, South Asia, Middle East & North Africa, Frost & Sullivan talks about how the local production of insulin from Novo Nordisk’s new plant in Iran could impact the pharma market more

Opinion

The Ministry of Health, Labor and Welfare in Japan has granted marketing authorisation for Sanofi's insulin glargine [rDNA origin] injection, 300 u/ml, a next-generation basal insulin for the treatment of type 1 and type 2 diabetes mellitus. more

News

Final-year Brunel University design student Oscar Daws has come up with a streamlined device that aims to vastly improve patients’ self-management of diabetes and has been selected for a prestigious exhibition on London’s South Bank. more

Technology

afrezza.jpg

Copyright: MannKind Corporation

The new rapid-acting inhaled insulin therapy is for treating adults with type 1 and type 2 diabetes. more

The acceptance of the NDA follows the acceptance of the marketing authorization dossier for Toujeo by the European Medicines Agency (EMA) for EU countries on 27 May 2014. more